Intravenous (IV) solutions are a complete mix of essential nutrients which are intended to replenish fluid losses, treat electrolyte imbalances and maintain fluid balance in intravenous therapy. They also provide required nutrients to the patients suffering from diabetes, cancer and other diseases. Intravenous solutions may contain water with electrolytes, sugar or medications added in concentrations as per the patient’s need. In line with this, the rate and quantity of these solutions varies depending on the medical condition, age and body size of the patient. According to IMARC Group’s latest report, titled “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global intravenous solutions market reached a value of US$ 7.5 Billion in 2017.
Prevalence of diseases, such as gastrointestinal disorder, neurological diseases, cancer and diabetes, due to unhealthy eating habits is the key factor for the growth of the intravenous solutions market. Moreover, as these solutions are available in portable packages, it becomes easier for the patients to use the drips at the comfort of their home rather than a hospital. Additionally, developing countries, such as India and China, are increasing their investment in the healthcare sector which is expected to drive the demand for intravenous solutions. Further, manufacturers are coming up with new product innovations such as introducing premixed solutions for better convenience and to reduce the amount of packaging waste. According to the report, the market is anticipated to reach a value of US$ 10.8 Billion by 2023, exhibiting a CAGR of 6.3% during 2018-2023.
The report has segmented the market on the basis of type into partial and total parenteral nutrition. The market has been further segregated on the basis of nutrients. The most popular types of nutrients include carbohydrates, salts and electrolytes, minerals, vitamins and amino acids. Region-wise, North America accounts for the majority of the total sales, followed by Europe and Asia Pacific. The report also covers the Middle East and Africa, and Latin America. The report has also analysed the competitive landscape of the market with some of the key global players being Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols and Otsuka Pharmaceutical.
This report provides a deep insight into the global intravenous solutions market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the intravenous solutions industry in any manner.
Key Questions Answered in This Report:
- How has the global intravenous solutions market performed so far and how will it perform in the coming years?
- What are the key regions in the global intravenous solutions market?
- Which are the popular types in the global intravenous solutions market?
- What are the major nutrients in the global intravenous solutions market?
- What are the various stages in the value chain of the global intravenous solutions market?
- What are the key driving factors and challenges in the global intravenous solutions market?
- What is the structure of the global intravenous solutions market and who are the key players?
- What is the degree of competition in the global intravenous solutions market?
- How are intravenous solutions manufactured?